Physician profile
Scott E Marsh
NPI 1679762827
$40,700.26
in general payments reported to CMS, 2019-2025
13 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $4,906 · 2021: $13K · 2022: $3,391 · 2023: $3,651 · 2024: $349 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,720 · Food and Beverage: $1,644 · Travel and Lodging: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,720.13 |
| Food and Beverage | $1,644.14 |
| Travel and Lodging | $134.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $27,426.51 | 2019-2022 | |
| Prosidyan, INC | $5,780.00 | 2021 | |
| Depuy Synthes Sales INC. | $4,460.25 | 2019-2025 | Na, Hammerlock, Fibulink |
| Depuy Synthes Products, INC. | $1,700.00 | 2022 | |
| Stryker Corporation | $559.96 | 2023-2025 | Inbone, Infinity Adaptis, 7 X 23mm Citrelock Implant |
| Cdc Medical LLC | $511.00 | 2019 | |
| Organogenesis INC. | $106.78 | 2020-2024 | |
| Smith+Nephew, INC. | $44.14 | 2022-2025 | Collagenase Santyl |
| Rock Medical Orthopedics, INC. | $30.77 | 2022 | |
| Orthofix Medical, INC. | $30.44 | 2025 | Physio-Stim |
| Convatec INC. | $19.93 | 2023 | |
| Solventum Corporation | $15.86 | 2024 | Prevena |
| Integra Lifesciences Corporation | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.